Stay updated on Avapritinib vs Regorafenib in GIST Clinical Trial
Sign up to get notified when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.

Latest updates to the Avapritinib vs Regorafenib in GIST Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedPubMed-based publication notes were updated to state that publications are automatically filled from PubMed and to include a new revision label (v3.3.2). The earlier PubMed note and revision label (v3.2.0) were removed.SummaryDifference0.1%

- Check26 days agoChange DetectedRemoved the government funding status notice; the study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check49 days agoChange DetectedNo significant changes observed between the old and new VOYAGER study pages for NCT03465722.SummaryDifference0.2%

- Check70 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.SummaryDifference2%

- Check77 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

- Check92 days agoChange DetectedThe revision label updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed. This is a minor maintenance update with no changes to core content.SummaryDifference0.1%

Stay in the know with updates to Avapritinib vs Regorafenib in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.